• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 UPLC-HRMS 的组织代谢组学检测和非小细胞肺癌分型。

Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.

机构信息

School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong 266003, P. R. China.

Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, P. R. China.

出版信息

J Proteome Res. 2022 Aug 5;21(8):2011-2022. doi: 10.1021/acs.jproteome.2c00316. Epub 2022 Jul 20.

DOI:10.1021/acs.jproteome.2c00316
PMID:35856400
Abstract

Non-small cell lung cancer (NSCLC) is the prevalent histological subtype of lung cancer. In this study, we performed ultraperformance liquid chromatography-high-resolution mass spectrometry (UPLC-HRMS)-based metabolic profiling of 227 tissue samples from 79 lung cancer patients with adenocarcinoma (AC) or squamous cell carcinoma (SCC). Orthogonal partial least squares-discriminant analysis (oPLS-DA) analyses showed that AC, SCC, and NSCLC tumors were discriminated from adjacent noncancerous tissue (ANT) and distant noncancerous tissue (DNT) samples with good accuracies (91.3, 100, and 88.3%), sensitivities (85.7, 100, and 83.9%), and specificities (94.3, 100, and 90.7%), using 12, 4, and 7 discriminant metabolites, respectively. The discriminant panel for AC detection included valine, sphingosine, glutamic acid γ-methyl ester, and lysophosphatidylcholine (LPC) (16:0), levels of which in tumor tissues were significantly altered. Valine, sphingosine, LPC (18:1), and leucine derivatives were used for SCC detection. The discrimination between AC and SCC had 96.8% accuracy, 98.2% sensitivity, and 85.7% specificity using a five-metabolite panel, of which valine and creatine had significant differences. The classification models were further verified with external validation sets, showing a promising prospect for NSCLC tissue detection and subtyping.

摘要

非小细胞肺癌(NSCLC)是肺癌中最常见的组织学亚型。在这项研究中,我们对 79 名肺癌患者的 227 个组织样本进行了基于超高效液相色谱-高分辨率质谱(UPLC-HRMS)的代谢组学分析,这些患者中包括腺癌(AC)或鳞状细胞癌(SCC)患者。正交偏最小二乘法判别分析(oPLS-DA)分析表明,AC、SCC 和 NSCLC 肿瘤可以与相邻非癌组织(ANT)和远处非癌组织(DNT)样本很好地区分,准确率分别为 91.3%、100%和 88.3%,灵敏度分别为 85.7%、100%和 83.9%,特异性分别为 94.3%、100%和 90.7%,使用了 12、4 和 7 个判别代谢物。AC 检测的判别面板包括缬氨酸、神经鞘氨醇、谷氨酸γ-甲酯和溶血磷脂酰胆碱(LPC)(16:0),其在肿瘤组织中的水平发生了显著改变。缬氨酸、神经鞘氨醇、LPC(18:1)和亮氨酸衍生物用于 SCC 检测。使用五代谢物面板对 AC 和 SCC 进行区分的准确率为 96.8%,灵敏度为 98.2%,特异性为 85.7%,其中缬氨酸和肌酸有显著差异。通过外部验证集进一步验证了分类模型,为 NSCLC 组织检测和亚型分类提供了有前景的前景。

相似文献

1
Non-Small Cell Lung Cancer Detection and Subtyping by UPLC-HRMS-Based Tissue Metabolomics.基于 UPLC-HRMS 的组织代谢组学检测和非小细胞肺癌分型。
J Proteome Res. 2022 Aug 5;21(8):2011-2022. doi: 10.1021/acs.jproteome.2c00316. Epub 2022 Jul 20.
2
Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues.非小细胞肺癌组织中神经酰胺、酰基肉碱、甘油三酯、LPLs 和胺的改变。
J Proteome Res. 2024 Oct 4;23(10):4343-4358. doi: 10.1021/acs.jproteome.4c00344. Epub 2024 Sep 24.
3
[Application of metabonomics examination in differential diagnosis of non-small cell lung cancer (NSCLC)].代谢组学检测在非小细胞肺癌(NSCLC)鉴别诊断中的应用
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019 Sep;35(9):838-842.
4
Development of LC-QTOF-MS method for human lung tissue fingerprinting. A preliminary application to nonsmall cell lung cancer.用于人肺组织指纹图谱分析的液相色谱-四极杆飞行时间质谱法的开发。在非小细胞肺癌中的初步应用。
Electrophoresis. 2017 Sep;38(18):2304-2312. doi: 10.1002/elps.201700022. Epub 2017 May 18.
5
Subtyping non-small cell lung cancer by histology-guided spatial metabolomics.基于组织学指导的空间代谢组学对非小细胞肺癌进行亚型分类。
J Cancer Res Clin Oncol. 2022 Feb;148(2):351-360. doi: 10.1007/s00432-021-03834-w. Epub 2021 Nov 28.
6
Metabolomic Profiling of Tumor Tissues Unveils Metabolic Shifts in Non-Small Cell Lung Cancer Patients with Concurrent Diabetes Mellitus.肿瘤组织代谢组学分析揭示合并糖尿病的非小细胞肺癌患者的代谢变化。
J Proteome Res. 2024 Sep 6;23(9):3746-3753. doi: 10.1021/acs.jproteome.3c00924. Epub 2024 Aug 20.
7
Changes in serum amino acid levels in non-small cell lung cancer: a case-control study in Chinese population.血清氨基酸水平在非小细胞肺癌中的变化:中国人群的病例对照研究。
PeerJ. 2022 Apr 20;10:e13272. doi: 10.7717/peerj.13272. eCollection 2022.
8
Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.皮质醇、可的松和4-甲氧基苯乙酸作为早期检测非小细胞肺癌的潜在血浆生物标志物。
Int J Biol Markers. 2018 Aug;33(3):314-320. doi: 10.1177/1724600818778754. Epub 2018 Jun 13.
9
Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.基于液相色谱-质谱联用的组织代谢组学分析揭示了肺癌的主要代谢途径改变和潜在的生物标志物。
J Proteome Res. 2020 Sep 4;19(9):3750-3760. doi: 10.1021/acs.jproteome.0c00285. Epub 2020 Jul 31.
10
Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.鉴定肺鳞癌和肺腺癌之间差异表达的 microRNAs。
Mol Med Rep. 2013 Aug;8(2):456-62. doi: 10.3892/mmr.2013.1517. Epub 2013 Jun 11.

引用本文的文献

1
[Applications and Advances of Metabolomics in Lung Cancer Research].[代谢组学在肺癌研究中的应用与进展]
Zhongguo Fei Ai Za Zhi. 2025 Jul 20;28(7):533-541. doi: 10.3779/j.issn.1009-3419.2025.106.20.
2
A comprehensive review on computational metabolomics: Advancing multiscale analysis through approaches.关于计算代谢组学的全面综述:通过多种方法推进多尺度分析。
Comput Struct Biotechnol J. 2025 Jul 13;27:3191-3215. doi: 10.1016/j.csbj.2025.07.016. eCollection 2025.
3
Determination of lung cancer exhaled breath biomarkers using machine learning-a new analysis framework.
使用机器学习确定肺癌呼出气体生物标志物——一种新的分析框架。
Sci Rep. 2025 Jul 18;15(1):26085. doi: 10.1038/s41598-025-11365-4.
4
Serum Metabolomics Study to Screen Potential Biomarkers of Lung Cancer Risk in High Natural Background Radiation Areas of Thailand: A Pilot Study.泰国高天然本底辐射地区肺癌风险潜在生物标志物筛查的血清代谢组学研究:一项初步研究。
Cancers (Basel). 2024 Dec 15;16(24):4182. doi: 10.3390/cancers16244182.
5
Lung Cancer Subtyping: A Short Review.肺癌亚型:简要综述
Cancers (Basel). 2024 Jul 25;16(15):2643. doi: 10.3390/cancers16152643.
6
Metabolomics Analysis and Diagnosis of Lung Cancer: Insights from Diverse Sample Types.代谢组学分析与肺癌诊断:来自不同样本类型的见解。
Int J Med Sci. 2024 Jan 1;21(2):234-252. doi: 10.7150/ijms.85704. eCollection 2024.